Adaptive Biotechnologies Corporation

US$27.98As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ADPTHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (7.15%)
Div yield —
ROE (36.44%)
Diagnostics & Research
Beta (5Y) 2.15
PE TTM —
TSR TTM 61.18%
Mkt cap US$4.529B
ROIC (5.96%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$28
0.94%
(49.41%)
Hold 9|3|11|12|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.28
0.27
0.30
0.32
6.61%
4.63%
17.24%
16.75%
Revenue$M
252.1
262.2
273.3
268.3
11.92%
11.93%
18.05%
12.13%
Peers (US$4.529B)
Cap (US$)
PE
5.376B
124.2x
4.573B
26.69x
4.128B
32.58x
4.511B
29.39x
Capital
TTM
5Y
10Y
Leveragex
2.014
0.060
0.048
EBIT/Intx
3.278
0.315
0.321
Own earn%
(59.18)
(155.42)
(150.25)
Sh yield%
41.27
43.43
43.67
Owners
Insiders/Inst%
1.49
82.10
Short interest%
2.21
SBC / revenue%
2.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
22–24
$1 testx
0.2
Incr. ROIC%
6